Who owns the LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY trademark?

The LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY trademark is owned by TRI-PHARMA Limited Liability Company.

What is the serial number for LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY?

The USPTO serial number for LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY is 79289157.

What is the registration number for LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY?

LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY is registered under USPTO registration number 6391873.

LIP

USPTO Trademark Record

REGISTERED

LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY

SN 79289157·Reg 6391873·Filed Apr 21, 2020

Owner TRI-PHARMA Limited Liability Company

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.; Transport; packaging and storage of goods; travel arrangement.

LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY (Serial No. 79289157), Registration No. 6391873, is a registered US trademark filed on Apr 21, 2020 by TRI-PHARMA Limited Liability Company. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services), Class 039 (Transportation, travel & storage services).

Renewal window: June 22, 2027255 days remaining

Mark Intelligence

LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY (Reg. #6391873) is a registered US trademark that has been protecting its owner, TRI-PHARMA Limited Liability Company, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services) and Class 039 (Transportation, travel & storage services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Apr 21, 2020

SERIAL

79289157

REG#

6391873

REGISTERED

Jun 22, 2021

Owner

Applicant

TRI-PHARMA Limited Liability Company

Entity

LLC

Address

Lineynaya street, building 30, office, 310, RU-630049 Novosibirsk

Country

Attorney

NameThomas Tatonetti

Law firm

Thomas Tatonetti Tatonetti IP

Docket

2070-1

Address

441 72nd Street, 2FL, Brooklyn, NY, 11209, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 21, 2020

Serial Number79289157

Registration No.6391873

Registration DateJun 22, 2021

Status DateJun 22, 2021

Published for OppositionApr 06, 2021

Mark TypeDesign with words

Attorney Docket2070-1

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 039Transportation, travel & storage services

US codes: 100, 105

Transport; packaging and storage of goods; travel arrangement.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

33 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jun 22, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Mar 12, 2022

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Dec 13, 2021

FINAL DECISION TRANSACTION PROCESSED BY IB

GENERIC MADRID TRANSACTION CREATED

Oct 13, 2021

GENERIC MADRID TRANSACTION CREATED

GENERIC MADRID TRANSACTION SENT TO IB

Oct 13, 2021

GENERIC MADRID TRANSACTION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Sep 22, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jun 22, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 06, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 06, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Apr 05, 2021

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 17, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Mar 17, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 17, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 02, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 01, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 01, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 01, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

FINAL REFUSAL WRITTEN

Feb 25, 2021

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Feb 25, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 25, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 02, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 02, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 01, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 23, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

REFUSAL PROCESSED BY IB

Aug 30, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Aug 11, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 11, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 18, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jul 17, 2020

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Jul 14, 2020

APPLICATION FILING RECEIPT MAILED

ASSIGNED TO EXAMINER

Jul 13, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 10, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jul 09, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Thomas Tatonetti

Resources

Company